4

PRIMARY DOCUMENT

Company: REVIVA PHARMACEUTICALS HOLDINGS, INC.
Filed: November 3, 2020
Period of Report: March 20, 2020
Accession Number: 0001393825-20-000131

View Document ↗ View on SEC.gov ↗